Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II

Acute HIT II (Heparin-induced Thrombocytopenia Type II) Clinical Trial

Official title: Systematische Dokumentation Von Patienten Mit Akutem HIT-Verdacht

Status Completed

Clinical Trial Summary

The purpose of this retrospective registry is to collect data about patients with acute HIT II (Heparin-induced Thrombocytopenia type II) which were treated with Lepirudin, Danaparoid, Argatroban or Fondaparinux. It is a main objective of this registry to mirror the daily routine in this indication in Germany.

Clinical Trial Description

n/a

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Acute HIT II (Heparin-induced Thrombocytopenia Type II)
• Thrombocytopenia
• Thrombocytosis

• NCT number: NCT01304238
• Study type: Observational
• Source: GlaxoSmithKline
• Status: Completed
• Phase: N/A
• Start date: February 2009
• Completion date: January 2010